Arvinas Announces Poster Presentation at ASCO 2019 Genitourinary Cancers Symposium

Author's Avatar
Feb 08, 2019
Article's Main Image

Company to Highlight ARV-110 PROTAC™ Protein Degrader for the Treatment of Prostate Cancer